Reiberger, Thomas

Baveno VII – Renewing consensus in portal hypertension

de Franchis, R., Bosch, J., Garcia-Tsao, G., Reiberger, T., Ripoll, C., Abraldes, J. G., Albillos, A., Baiges, A., Bajaj, J., Bañares, R., et al. (2022) · Journal of Hepatology

Liver Disease and TransplantationLiver Disease Diagnosis and Treatment

Cited by 2,930

CXCR4 inhibition in tumor microenvironment facilitates anti‐programmed death receptor‐1 immunotherapy in sorafenib‐treated hepatocellular carcinoma in mice

Chen, Y., Ramjiawan, R. R., Reiberger, T., Ng, M. R., Hato, T., Huang, Y., Ochiai, H., Kitahara, S., Unan, E. C., Reddy, T. P., et al. (2015) · Hepatology

Cancer Immunotherapy and BiomarkersHepatocellular Carcinoma Treatment and Prognosis

Cited by 451

Inflammasomes in chronic liver disease: hepatic injury, fibrosis progression and systemic inflammation

Taru, V., Szabo, G., Mehal, W., & Reiberger, T. (2024) · Journal of Hepatology

Inflammasome and immune disordersLiver physiology and pathology

Cited by 344

Noninvasive diagnosis of portal hypertension in patients with compensated advanced chronic liver disease

Pons, M., Augustin, S., Scheiner, B., Guillaume, M., Rosselli, M., Rodrigues, S. G., Stefanescu, H., Ma, M. M., Mandorfer, M., Mergeay-Fabre, M., et al. (2021) · American Journal of Gastroenterology

Liver Disease and TransplantationLiver Disease Diagnosis and Treatment

Cited by 260

The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction

Schwabl, P., Hambruch, E., Seeland, B. A., Hayden, H., Wagner, M., Garnys, L., Strobel, B., Schubert, T.-L., Riedl, F., Mitteregger, D., et al. (2017) · Journal of Hepatology

Liver Disease and TransplantationLiver physiology and pathology

Cited by 178

Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis

Dajti, E., Ravaioli, F., Zykus, R., Rautou, P.-E., Elkrief, L., Grgurevic, I., Stefanescu, H., Hirooka, M., Fraquelli, M., Rosselli, M., et al. (2023) · The Lancet Gastroenterology & Hepatology

Liver Disease and TransplantationLiver Disease Diagnosis and Treatment

Cited by 109

E-AHPBA-ESSO-ESSR Innsbruck consensus guidelines for preoperative liver function assessment before hepatectomy

Primavesi, F., Maglione, M., Cipriani, F., Denecke, T., Oberkofler, C. E., Starlinger, P., Dasari, B. V. M., Heil, J., Sgarbura, O., Søreide, K., et al. (2023) · British Journal of Surgery

Hepatocellular Carcinoma Treatment and PrognosisOrgan Transplantation Techniques and Outcomes

Cited by 97

The value of different CT‐based methods for diagnosing low muscle mass and predicting mortality in patients with cirrhosis

Paternostro, R., Lampichler, K., Bardach, C., Asenbaum, U., Landler, C., Bauer, D., Mandorfer, M., Schwarzer, R., Trauner, M., Reiberger, T., et al. (2019) · Liver International

Nutrition and Health in AgingLiver Disease and Transplantation

Cited by 71

The non-steroidal FXR agonist cilofexor improves portal hypertension and reduces hepatic fibrosis in a rat NASH model

Schwabl, P., Hambruch, E., Budas, G. R., Supper, P., Burnet, M., Liles, J. T., Birkel, M., Brusilovskaya, K., Königshofer, P., Peck-Radosavljevic, M., et al. (2021) · Biomedicines

Liver Disease Diagnosis and TreatmentLiver physiology and pathology

Cited by 70

Prognostic impact of sarcopenia in cirrhotic patients stratified by different severity of portal hypertension

Paternostro, R., Bardach, C., Hofer, B. S., Scheiner, B., Schwabl, P., Asenbaum, U., Ba‐Ssalamah, A., Scharitzer, M., Bucscis, T., Simbrunner, B., et al. (2021) · Liver International

Liver Disease and TransplantationNutrition and Health in Aging

Cited by 46

Nuclear receptors in liver fibrosis

Königshofer, P., Brusilovskaya, K., Petrenko, O., Hofer, B. S., Schwabl, P., Trauner, M., & Reiberger, T. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Liver physiology and pathologyLiver Disease Diagnosis and Treatment

Cited by 45

Transjugular aspiration liver biopsy performed by hepatologists trained in HVPG measurements is safe and provides important diagnostic information

Stift, J., Semmler, G., Walzel, C., Mandorfer, M., Schwarzer, R., Schwabl, P., Paternostro, R., Scheiner, B., Wöran, K., Pinter, M., et al. (2019) · Digestive and Liver Disease

Liver Disease and TransplantationLiver Disease Diagnosis and Treatment

Cited by 34

Vascular targets for the treatment of portal hypertension

Brusilovskaya, K., Königshofer, P., Schwabl, P., & Reiberger, T. (2019) · Seminars in Liver Disease

Liver Disease and TransplantationLiver physiology and pathology

Cited by 28

Liver Capsule: FXR agonists against liver disease

Fuchs, C. D., Schwabl, P., Reiberger, T., & Trauner, M. (2016) · Hepatology

Drug Transport and Resistance MechanismsLiver Disease Diagnosis and Treatment

Cited by 20

Comparison of the diagnostic quality of aspiration and core-biopsy needles for transjugular liver biopsy

Stift, J., Semmler, G., Wöran, K., Simbrunner, B., Scheiner, B., Schwabl, P., Paternostro, R., Pinter, M., Stättermayer, A. F., Meischl, T., et al. (2020) · Digestive and Liver Disease

Liver Disease Diagnosis and TreatmentLiver Disease and Transplantation

Cited by 16